nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—SLC22A2—Cisplatin—urinary bladder cancer	0.0979	0.384	CbGbCtD
Histamine Phosphate—CYP3A4—Thiotepa—urinary bladder cancer	0.0566	0.222	CbGbCtD
Histamine Phosphate—CYP2C9—Fluorouracil—urinary bladder cancer	0.0316	0.124	CbGbCtD
Histamine Phosphate—CYP2C9—Cisplatin—urinary bladder cancer	0.0269	0.105	CbGbCtD
Histamine Phosphate—CYP2D6—Doxorubicin—urinary bladder cancer	0.0165	0.0645	CbGbCtD
Histamine Phosphate—CYP3A4—Etoposide—urinary bladder cancer	0.0153	0.0601	CbGbCtD
Histamine Phosphate—CYP3A4—Doxorubicin—urinary bladder cancer	0.0105	0.041	CbGbCtD
Histamine Phosphate—HNMT—prostate gland—urinary bladder cancer	0.0103	0.0666	CbGeAlD
Histamine Phosphate—CYP2C9—urine—urinary bladder cancer	0.00856	0.0553	CbGeAlD
Histamine Phosphate—HNMT—epithelium—urinary bladder cancer	0.00758	0.049	CbGeAlD
Histamine Phosphate—HNMT—renal system—urinary bladder cancer	0.00703	0.0454	CbGeAlD
Histamine Phosphate—CYP3A4—urine—urinary bladder cancer	0.00653	0.0421	CbGeAlD
Histamine Phosphate—CYP2D6—urine—urinary bladder cancer	0.00642	0.0415	CbGeAlD
Histamine Phosphate—HNMT—female reproductive system—urinary bladder cancer	0.00563	0.0364	CbGeAlD
Histamine Phosphate—HNMT—vagina—urinary bladder cancer	0.0051	0.0329	CbGeAlD
Histamine Phosphate—SLC22A2—renal system—urinary bladder cancer	0.00496	0.032	CbGeAlD
Histamine Phosphate—SLC22A3—prostate gland—urinary bladder cancer	0.00491	0.0317	CbGeAlD
Histamine Phosphate—CA4—prostate gland—urinary bladder cancer	0.00438	0.0283	CbGeAlD
Histamine Phosphate—SLC22A3—seminal vesicle—urinary bladder cancer	0.00416	0.0268	CbGeAlD
Histamine Phosphate—CA4—seminal vesicle—urinary bladder cancer	0.0037	0.0239	CbGeAlD
Histamine Phosphate—SLC22A5—prostate gland—urinary bladder cancer	0.00357	0.0231	CbGeAlD
Histamine Phosphate—SLC22A1—renal system—urinary bladder cancer	0.0035	0.0226	CbGeAlD
Histamine Phosphate—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.00348	0.0225	CbGeAlD
Histamine Phosphate—Risedronate—PTGS2—urinary bladder cancer	0.0034	1	CrCbGaD
Histamine Phosphate—SLC22A3—renal system—urinary bladder cancer	0.00335	0.0216	CbGeAlD
Histamine Phosphate—HNMT—lymph node—urinary bladder cancer	0.0033	0.0213	CbGeAlD
Histamine Phosphate—SLC22A3—urethra—urinary bladder cancer	0.00329	0.0212	CbGeAlD
Histamine Phosphate—HRH1—prostate gland—urinary bladder cancer	0.00303	0.0196	CbGeAlD
Histamine Phosphate—SLC22A5—seminal vesicle—urinary bladder cancer	0.00302	0.0195	CbGeAlD
Histamine Phosphate—CA4—renal system—urinary bladder cancer	0.00298	0.0193	CbGeAlD
Histamine Phosphate—CA4—urethra—urinary bladder cancer	0.00293	0.0189	CbGeAlD
Histamine Phosphate—SLC22A3—female reproductive system—urinary bladder cancer	0.00268	0.0173	CbGeAlD
Histamine Phosphate—HRH2—lymph node—urinary bladder cancer	0.00255	0.0165	CbGeAlD
Histamine Phosphate—SLC22A1—vagina—urinary bladder cancer	0.00254	0.0164	CbGeAlD
Histamine Phosphate—SLC22A5—renal system—urinary bladder cancer	0.00243	0.0157	CbGeAlD
Histamine Phosphate—SLC22A3—vagina—urinary bladder cancer	0.00243	0.0157	CbGeAlD
Histamine Phosphate—SLC22A5—urethra—urinary bladder cancer	0.00239	0.0154	CbGeAlD
Histamine Phosphate—CA4—female reproductive system—urinary bladder cancer	0.00239	0.0154	CbGeAlD
Histamine Phosphate—HRH1—epithelium—urinary bladder cancer	0.00223	0.0144	CbGeAlD
Histamine Phosphate—HRH1—smooth muscle tissue—urinary bladder cancer	0.00215	0.0139	CbGeAlD
Histamine Phosphate—HRH1—urethra—urinary bladder cancer	0.00203	0.0131	CbGeAlD
Histamine Phosphate—SLC22A5—female reproductive system—urinary bladder cancer	0.00195	0.0126	CbGeAlD
Histamine Phosphate—SLC22A5—vagina—urinary bladder cancer	0.00176	0.0114	CbGeAlD
Histamine Phosphate—CYP2C9—female reproductive system—urinary bladder cancer	0.00168	0.0108	CbGeAlD
Histamine Phosphate—HRH1—female reproductive system—urinary bladder cancer	0.00165	0.0107	CbGeAlD
Histamine Phosphate—CYP3A4—renal system—urinary bladder cancer	0.0016	0.0103	CbGeAlD
Histamine Phosphate—CYP2D6—renal system—urinary bladder cancer	0.00157	0.0101	CbGeAlD
Histamine Phosphate—SLC22A3—lymph node—urinary bladder cancer	0.00157	0.0101	CbGeAlD
Histamine Phosphate—HRH1—vagina—urinary bladder cancer	0.0015	0.00966	CbGeAlD
Histamine Phosphate—CA4—lymph node—urinary bladder cancer	0.0014	0.00903	CbGeAlD
Histamine Phosphate—CYP3A4—female reproductive system—urinary bladder cancer	0.00128	0.00826	CbGeAlD
Histamine Phosphate—CYP2D6—female reproductive system—urinary bladder cancer	0.00126	0.00812	CbGeAlD
Histamine Phosphate—SLC22A5—lymph node—urinary bladder cancer	0.00114	0.00737	CbGeAlD
Histamine Phosphate—HRH1—lymph node—urinary bladder cancer	0.000967	0.00625	CbGeAlD
Histamine Phosphate—Rash—Thiotepa—urinary bladder cancer	0.000478	0.000996	CcSEcCtD
Histamine Phosphate—Dermatitis—Thiotepa—urinary bladder cancer	0.000478	0.000995	CcSEcCtD
Histamine Phosphate—Headache—Thiotepa—urinary bladder cancer	0.000475	0.000989	CcSEcCtD
Histamine Phosphate—Decreased appetite—Etoposide—urinary bladder cancer	0.000474	0.000986	CcSEcCtD
Histamine Phosphate—Renal failure—Epirubicin—urinary bladder cancer	0.000471	0.00098	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000471	0.000979	CcSEcCtD
Histamine Phosphate—Body temperature increased—Cisplatin—urinary bladder cancer	0.00047	0.000979	CcSEcCtD
Histamine Phosphate—Fatigue—Etoposide—urinary bladder cancer	0.00047	0.000978	CcSEcCtD
Histamine Phosphate—Stomatitis—Epirubicin—urinary bladder cancer	0.000467	0.000972	CcSEcCtD
Histamine Phosphate—Pain—Etoposide—urinary bladder cancer	0.000466	0.00097	CcSEcCtD
Histamine Phosphate—Constipation—Etoposide—urinary bladder cancer	0.000466	0.00097	CcSEcCtD
Histamine Phosphate—Neutropenia—Doxorubicin—urinary bladder cancer	0.000465	0.000967	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000462	0.000962	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000462	0.000962	CcSEcCtD
Histamine Phosphate—Asthenia—Gemcitabine—urinary bladder cancer	0.000458	0.000953	CcSEcCtD
Histamine Phosphate—Weight increased—Doxorubicin—urinary bladder cancer	0.000452	0.000942	CcSEcCtD
Histamine Phosphate—Pruritus—Gemcitabine—urinary bladder cancer	0.000452	0.00094	CcSEcCtD
Histamine Phosphate—Nausea—Thiotepa—urinary bladder cancer	0.000451	0.000938	CcSEcCtD
Histamine Phosphate—Weight decreased—Doxorubicin—urinary bladder cancer	0.00045	0.000936	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Etoposide—urinary bladder cancer	0.000449	0.000935	CcSEcCtD
Histamine Phosphate—Pneumonia—Doxorubicin—urinary bladder cancer	0.000446	0.000928	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000446	0.000928	CcSEcCtD
Histamine Phosphate—Pruritus—Fluorouracil—urinary bladder cancer	0.000444	0.000924	CcSEcCtD
Histamine Phosphate—Infestation—Doxorubicin—urinary bladder cancer	0.000443	0.000922	CcSEcCtD
Histamine Phosphate—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000443	0.000922	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000438	0.000912	CcSEcCtD
Histamine Phosphate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000437	0.000909	CcSEcCtD
Histamine Phosphate—Renal failure—Doxorubicin—urinary bladder cancer	0.000436	0.000907	CcSEcCtD
Histamine Phosphate—Urticaria—Etoposide—urinary bladder cancer	0.000433	0.000901	CcSEcCtD
Histamine Phosphate—Stomatitis—Doxorubicin—urinary bladder cancer	0.000432	0.000899	CcSEcCtD
Histamine Phosphate—Abdominal pain—Etoposide—urinary bladder cancer	0.000431	0.000897	CcSEcCtD
Histamine Phosphate—Body temperature increased—Etoposide—urinary bladder cancer	0.000431	0.000897	CcSEcCtD
Histamine Phosphate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000429	0.000894	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000428	0.00089	CcSEcCtD
Histamine Phosphate—Asthenia—Cisplatin—urinary bladder cancer	0.000427	0.000888	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000426	0.000888	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000424	0.000882	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000423	0.000879	CcSEcCtD
Histamine Phosphate—Angiopathy—Methotrexate—urinary bladder cancer	0.000417	0.000868	CcSEcCtD
Histamine Phosphate—Dizziness—Fluorouracil—urinary bladder cancer	0.000415	0.000864	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000414	0.000862	CcSEcCtD
Histamine Phosphate—Chills—Methotrexate—urinary bladder cancer	0.000412	0.000858	CcSEcCtD
Histamine Phosphate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000407	0.000847	CcSEcCtD
Histamine Phosphate—Vomiting—Gemcitabine—urinary bladder cancer	0.000406	0.000845	CcSEcCtD
Histamine Phosphate—Mental disorder—Methotrexate—urinary bladder cancer	0.000403	0.000838	CcSEcCtD
Histamine Phosphate—Rash—Gemcitabine—urinary bladder cancer	0.000402	0.000838	CcSEcCtD
Histamine Phosphate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000402	0.000837	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000402	0.000836	CcSEcCtD
Histamine Phosphate—Erythema—Methotrexate—urinary bladder cancer	0.0004	0.000832	CcSEcCtD
Histamine Phosphate—Malnutrition—Methotrexate—urinary bladder cancer	0.0004	0.000832	CcSEcCtD
Histamine Phosphate—Headache—Gemcitabine—urinary bladder cancer	0.0004	0.000832	CcSEcCtD
Histamine Phosphate—Flushing—Epirubicin—urinary bladder cancer	0.000399	0.000831	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000399	0.000831	CcSEcCtD
Histamine Phosphate—Vomiting—Fluorouracil—urinary bladder cancer	0.000399	0.00083	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000396	0.000824	CcSEcCtD
Histamine Phosphate—Rash—Fluorouracil—urinary bladder cancer	0.000396	0.000823	CcSEcCtD
Histamine Phosphate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000395	0.000823	CcSEcCtD
Histamine Phosphate—Headache—Fluorouracil—urinary bladder cancer	0.000393	0.000818	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000392	0.000816	CcSEcCtD
Histamine Phosphate—Dysgeusia—Methotrexate—urinary bladder cancer	0.000392	0.000815	CcSEcCtD
Histamine Phosphate—Asthenia—Etoposide—urinary bladder cancer	0.000391	0.000814	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000391	0.000814	CcSEcCtD
Histamine Phosphate—Angiopathy—Epirubicin—urinary bladder cancer	0.00039	0.000812	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000388	0.000807	CcSEcCtD
Histamine Phosphate—Back pain—Methotrexate—urinary bladder cancer	0.000387	0.000805	CcSEcCtD
Histamine Phosphate—Chills—Epirubicin—urinary bladder cancer	0.000386	0.000803	CcSEcCtD
Histamine Phosphate—Pruritus—Etoposide—urinary bladder cancer	0.000386	0.000803	CcSEcCtD
Histamine Phosphate—Arrhythmia—Epirubicin—urinary bladder cancer	0.000384	0.000799	CcSEcCtD
Histamine Phosphate—Nausea—Gemcitabine—urinary bladder cancer	0.000379	0.000789	CcSEcCtD
Histamine Phosphate—Vomiting—Cisplatin—urinary bladder cancer	0.000378	0.000787	CcSEcCtD
Histamine Phosphate—Mental disorder—Epirubicin—urinary bladder cancer	0.000377	0.000784	CcSEcCtD
Histamine Phosphate—Rash—Cisplatin—urinary bladder cancer	0.000375	0.000781	CcSEcCtD
Histamine Phosphate—Dermatitis—Cisplatin—urinary bladder cancer	0.000375	0.00078	CcSEcCtD
Histamine Phosphate—Malnutrition—Epirubicin—urinary bladder cancer	0.000374	0.000779	CcSEcCtD
Histamine Phosphate—Erythema—Epirubicin—urinary bladder cancer	0.000374	0.000779	CcSEcCtD
Histamine Phosphate—Diarrhoea—Etoposide—urinary bladder cancer	0.000373	0.000776	CcSEcCtD
Histamine Phosphate—Nausea—Fluorouracil—urinary bladder cancer	0.000373	0.000776	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000371	0.000772	CcSEcCtD
Histamine Phosphate—Anaemia—Methotrexate—urinary bladder cancer	0.00037	0.000769	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000369	0.000769	CcSEcCtD
Histamine Phosphate—Flushing—Doxorubicin—urinary bladder cancer	0.000369	0.000769	CcSEcCtD
Histamine Phosphate—Flatulence—Epirubicin—urinary bladder cancer	0.000369	0.000768	CcSEcCtD
Histamine Phosphate—Dysgeusia—Epirubicin—urinary bladder cancer	0.000367	0.000763	CcSEcCtD
Histamine Phosphate—Back pain—Epirubicin—urinary bladder cancer	0.000362	0.000754	CcSEcCtD
Histamine Phosphate—Angiopathy—Doxorubicin—urinary bladder cancer	0.000361	0.000751	CcSEcCtD
Histamine Phosphate—Malaise—Methotrexate—urinary bladder cancer	0.000361	0.000751	CcSEcCtD
Histamine Phosphate—Dizziness—Etoposide—urinary bladder cancer	0.00036	0.00075	CcSEcCtD
Histamine Phosphate—Muscle spasms—Epirubicin—urinary bladder cancer	0.00036	0.000749	CcSEcCtD
Histamine Phosphate—Vertigo—Methotrexate—urinary bladder cancer	0.000359	0.000748	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000359	0.000746	CcSEcCtD
Histamine Phosphate—Leukopenia—Methotrexate—urinary bladder cancer	0.000358	0.000745	CcSEcCtD
Histamine Phosphate—Chills—Doxorubicin—urinary bladder cancer	0.000357	0.000743	CcSEcCtD
Histamine Phosphate—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000355	0.00074	CcSEcCtD
Histamine Phosphate—Nausea—Cisplatin—urinary bladder cancer	0.000353	0.000735	CcSEcCtD
Histamine Phosphate—Cough—Methotrexate—urinary bladder cancer	0.000349	0.000726	CcSEcCtD
Histamine Phosphate—Mental disorder—Doxorubicin—urinary bladder cancer	0.000349	0.000725	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000347	0.000723	CcSEcCtD
Histamine Phosphate—Convulsion—Methotrexate—urinary bladder cancer	0.000347	0.000721	CcSEcCtD
Histamine Phosphate—Vomiting—Etoposide—urinary bladder cancer	0.000347	0.000721	CcSEcCtD
Histamine Phosphate—Erythema—Doxorubicin—urinary bladder cancer	0.000346	0.000721	CcSEcCtD
Histamine Phosphate—Malnutrition—Doxorubicin—urinary bladder cancer	0.000346	0.000721	CcSEcCtD
Histamine Phosphate—Anaemia—Epirubicin—urinary bladder cancer	0.000346	0.00072	CcSEcCtD
Histamine Phosphate—Rash—Etoposide—urinary bladder cancer	0.000344	0.000715	CcSEcCtD
Histamine Phosphate—Dermatitis—Etoposide—urinary bladder cancer	0.000343	0.000715	CcSEcCtD
Histamine Phosphate—Headache—Etoposide—urinary bladder cancer	0.000341	0.000711	CcSEcCtD
Histamine Phosphate—Flatulence—Doxorubicin—urinary bladder cancer	0.000341	0.00071	CcSEcCtD
Histamine Phosphate—Chest pain—Methotrexate—urinary bladder cancer	0.000341	0.000709	CcSEcCtD
Histamine Phosphate—Arthralgia—Methotrexate—urinary bladder cancer	0.000341	0.000709	CcSEcCtD
Histamine Phosphate—Myalgia—Methotrexate—urinary bladder cancer	0.000341	0.000709	CcSEcCtD
Histamine Phosphate—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000339	0.000706	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000338	0.000704	CcSEcCtD
Histamine Phosphate—Malaise—Epirubicin—urinary bladder cancer	0.000338	0.000703	CcSEcCtD
Histamine Phosphate—Discomfort—Methotrexate—urinary bladder cancer	0.000336	0.0007	CcSEcCtD
Histamine Phosphate—Vertigo—Epirubicin—urinary bladder cancer	0.000336	0.0007	CcSEcCtD
Histamine Phosphate—Leukopenia—Epirubicin—urinary bladder cancer	0.000335	0.000697	CcSEcCtD
Histamine Phosphate—Back pain—Doxorubicin—urinary bladder cancer	0.000335	0.000697	CcSEcCtD
Histamine Phosphate—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000333	0.000693	CcSEcCtD
Histamine Phosphate—Palpitations—Epirubicin—urinary bladder cancer	0.000331	0.000688	CcSEcCtD
Histamine Phosphate—Confusional state—Methotrexate—urinary bladder cancer	0.000329	0.000685	CcSEcCtD
Histamine Phosphate—Cough—Epirubicin—urinary bladder cancer	0.000327	0.00068	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000326	0.000679	CcSEcCtD
Histamine Phosphate—Convulsion—Epirubicin—urinary bladder cancer	0.000324	0.000675	CcSEcCtD
Histamine Phosphate—Infection—Methotrexate—urinary bladder cancer	0.000324	0.000675	CcSEcCtD
Histamine Phosphate—Nausea—Etoposide—urinary bladder cancer	0.000324	0.000674	CcSEcCtD
Histamine Phosphate—Hypertension—Epirubicin—urinary bladder cancer	0.000323	0.000673	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000321	0.000669	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00032	0.000666	CcSEcCtD
Histamine Phosphate—Anaemia—Doxorubicin—urinary bladder cancer	0.00032	0.000666	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00032	0.000665	CcSEcCtD
Histamine Phosphate—Arthralgia—Epirubicin—urinary bladder cancer	0.000319	0.000663	CcSEcCtD
Histamine Phosphate—Myalgia—Epirubicin—urinary bladder cancer	0.000319	0.000663	CcSEcCtD
Histamine Phosphate—Chest pain—Epirubicin—urinary bladder cancer	0.000319	0.000663	CcSEcCtD
Histamine Phosphate—Anxiety—Epirubicin—urinary bladder cancer	0.000318	0.000661	CcSEcCtD
Histamine Phosphate—Skin disorder—Methotrexate—urinary bladder cancer	0.000317	0.00066	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000317	0.000659	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000316	0.000657	CcSEcCtD
Histamine Phosphate—Discomfort—Epirubicin—urinary bladder cancer	0.000315	0.000655	CcSEcCtD
Histamine Phosphate—Malaise—Doxorubicin—urinary bladder cancer	0.000312	0.00065	CcSEcCtD
Histamine Phosphate—Dry mouth—Epirubicin—urinary bladder cancer	0.000312	0.000649	CcSEcCtD
Histamine Phosphate—Vertigo—Doxorubicin—urinary bladder cancer	0.000311	0.000648	CcSEcCtD
Histamine Phosphate—Anorexia—Methotrexate—urinary bladder cancer	0.000311	0.000648	CcSEcCtD
Histamine Phosphate—Leukopenia—Doxorubicin—urinary bladder cancer	0.00031	0.000645	CcSEcCtD
Histamine Phosphate—Confusional state—Epirubicin—urinary bladder cancer	0.000308	0.000641	CcSEcCtD
Histamine Phosphate—Palpitations—Doxorubicin—urinary bladder cancer	0.000306	0.000637	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000306	0.000636	CcSEcCtD
Histamine Phosphate—Hypotension—Methotrexate—urinary bladder cancer	0.000305	0.000635	CcSEcCtD
Histamine Phosphate—Infection—Epirubicin—urinary bladder cancer	0.000304	0.000632	CcSEcCtD
Histamine Phosphate—Cough—Doxorubicin—urinary bladder cancer	0.000302	0.000629	CcSEcCtD
Histamine Phosphate—Shock—Epirubicin—urinary bladder cancer	0.000301	0.000626	CcSEcCtD
Histamine Phosphate—Convulsion—Doxorubicin—urinary bladder cancer	0.0003	0.000625	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Epirubicin—urinary bladder cancer	0.0003	0.000624	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000299	0.000623	CcSEcCtD
Histamine Phosphate—Hypertension—Doxorubicin—urinary bladder cancer	0.000299	0.000622	CcSEcCtD
Histamine Phosphate—Tachycardia—Epirubicin—urinary bladder cancer	0.000298	0.000621	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000297	0.000619	CcSEcCtD
Histamine Phosphate—Skin disorder—Epirubicin—urinary bladder cancer	0.000297	0.000618	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000295	0.000615	CcSEcCtD
Histamine Phosphate—Insomnia—Methotrexate—urinary bladder cancer	0.000295	0.000615	CcSEcCtD
Histamine Phosphate—Chest pain—Doxorubicin—urinary bladder cancer	0.000295	0.000614	CcSEcCtD
Histamine Phosphate—Arthralgia—Doxorubicin—urinary bladder cancer	0.000295	0.000614	CcSEcCtD
Histamine Phosphate—Myalgia—Doxorubicin—urinary bladder cancer	0.000295	0.000614	CcSEcCtD
Histamine Phosphate—Anxiety—Doxorubicin—urinary bladder cancer	0.000294	0.000612	CcSEcCtD
Histamine Phosphate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000293	0.00061	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000293	0.000609	CcSEcCtD
Histamine Phosphate—Discomfort—Doxorubicin—urinary bladder cancer	0.000291	0.000606	CcSEcCtD
Histamine Phosphate—Anorexia—Epirubicin—urinary bladder cancer	0.000291	0.000606	CcSEcCtD
Histamine Phosphate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000291	0.000606	CcSEcCtD
Histamine Phosphate—Dry mouth—Doxorubicin—urinary bladder cancer	0.000288	0.0006	CcSEcCtD
Histamine Phosphate—Dyspepsia—Methotrexate—urinary bladder cancer	0.000287	0.000598	CcSEcCtD
Histamine Phosphate—Hypotension—Epirubicin—urinary bladder cancer	0.000285	0.000594	CcSEcCtD
Histamine Phosphate—Confusional state—Doxorubicin—urinary bladder cancer	0.000285	0.000593	CcSEcCtD
Histamine Phosphate—Decreased appetite—Methotrexate—urinary bladder cancer	0.000284	0.000591	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000283	0.000588	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000282	0.000587	CcSEcCtD
Histamine Phosphate—Fatigue—Methotrexate—urinary bladder cancer	0.000281	0.000586	CcSEcCtD
Histamine Phosphate—Infection—Doxorubicin—urinary bladder cancer	0.000281	0.000584	CcSEcCtD
Histamine Phosphate—Pain—Methotrexate—urinary bladder cancer	0.000279	0.000581	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000278	0.000579	CcSEcCtD
Histamine Phosphate—Shock—Doxorubicin—urinary bladder cancer	0.000278	0.000579	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000277	0.000577	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000277	0.000576	CcSEcCtD
Histamine Phosphate—Insomnia—Epirubicin—urinary bladder cancer	0.000276	0.000575	CcSEcCtD
Histamine Phosphate—Tachycardia—Doxorubicin—urinary bladder cancer	0.000276	0.000574	CcSEcCtD
Histamine Phosphate—Skin disorder—Doxorubicin—urinary bladder cancer	0.000275	0.000571	CcSEcCtD
Histamine Phosphate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000274	0.000571	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000273	0.000569	CcSEcCtD
Histamine Phosphate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000272	0.000567	CcSEcCtD
Histamine Phosphate—Anorexia—Doxorubicin—urinary bladder cancer	0.000269	0.000561	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000269	0.00056	CcSEcCtD
Histamine Phosphate—Dyspepsia—Epirubicin—urinary bladder cancer	0.000269	0.00056	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000267	0.000556	CcSEcCtD
Histamine Phosphate—Decreased appetite—Epirubicin—urinary bladder cancer	0.000266	0.000553	CcSEcCtD
Histamine Phosphate—Hypotension—Doxorubicin—urinary bladder cancer	0.000264	0.00055	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000264	0.000549	CcSEcCtD
Histamine Phosphate—Fatigue—Epirubicin—urinary bladder cancer	0.000263	0.000548	CcSEcCtD
Histamine Phosphate—Pain—Epirubicin—urinary bladder cancer	0.000261	0.000544	CcSEcCtD
Histamine Phosphate—Constipation—Epirubicin—urinary bladder cancer	0.000261	0.000544	CcSEcCtD
Histamine Phosphate—Urticaria—Methotrexate—urinary bladder cancer	0.000259	0.00054	CcSEcCtD
Histamine Phosphate—Abdominal pain—Methotrexate—urinary bladder cancer	0.000258	0.000537	CcSEcCtD
Histamine Phosphate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000258	0.000537	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000258	0.000536	CcSEcCtD
Histamine Phosphate—Insomnia—Doxorubicin—urinary bladder cancer	0.000256	0.000532	CcSEcCtD
Histamine Phosphate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000254	0.000528	CcSEcCtD
Histamine Phosphate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000252	0.000525	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000252	0.000524	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00025	0.00052	CcSEcCtD
Histamine Phosphate—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000249	0.000518	CcSEcCtD
Histamine Phosphate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000246	0.000511	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000244	0.000508	CcSEcCtD
Histamine Phosphate—Fatigue—Doxorubicin—urinary bladder cancer	0.000244	0.000507	CcSEcCtD
Histamine Phosphate—Urticaria—Epirubicin—urinary bladder cancer	0.000243	0.000505	CcSEcCtD
Histamine Phosphate—Pain—Doxorubicin—urinary bladder cancer	0.000242	0.000503	CcSEcCtD
Histamine Phosphate—Constipation—Doxorubicin—urinary bladder cancer	0.000242	0.000503	CcSEcCtD
Histamine Phosphate—Abdominal pain—Epirubicin—urinary bladder cancer	0.000242	0.000503	CcSEcCtD
Histamine Phosphate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000242	0.000503	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000241	0.000501	CcSEcCtD
Histamine Phosphate—Asthenia—Methotrexate—urinary bladder cancer	0.000234	0.000487	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000233	0.000485	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000231	0.000481	CcSEcCtD
Histamine Phosphate—Pruritus—Methotrexate—urinary bladder cancer	0.000231	0.000481	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000225	0.000468	CcSEcCtD
Histamine Phosphate—Urticaria—Doxorubicin—urinary bladder cancer	0.000225	0.000467	CcSEcCtD
Histamine Phosphate—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000223	0.000465	CcSEcCtD
Histamine Phosphate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000223	0.000465	CcSEcCtD
Histamine Phosphate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000223	0.000465	CcSEcCtD
Histamine Phosphate—Asthenia—Epirubicin—urinary bladder cancer	0.000219	0.000456	CcSEcCtD
Histamine Phosphate—Pruritus—Epirubicin—urinary bladder cancer	0.000216	0.00045	CcSEcCtD
Histamine Phosphate—Dizziness—Methotrexate—urinary bladder cancer	0.000216	0.000449	CcSEcCtD
Histamine Phosphate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000209	0.000435	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000208	0.000433	CcSEcCtD
Histamine Phosphate—Vomiting—Methotrexate—urinary bladder cancer	0.000208	0.000432	CcSEcCtD
Histamine Phosphate—Rash—Methotrexate—urinary bladder cancer	0.000206	0.000428	CcSEcCtD
Histamine Phosphate—Dermatitis—Methotrexate—urinary bladder cancer	0.000206	0.000428	CcSEcCtD
Histamine Phosphate—Headache—Methotrexate—urinary bladder cancer	0.000205	0.000426	CcSEcCtD
Histamine Phosphate—Asthenia—Doxorubicin—urinary bladder cancer	0.000203	0.000422	CcSEcCtD
Histamine Phosphate—Dizziness—Epirubicin—urinary bladder cancer	0.000202	0.00042	CcSEcCtD
Histamine Phosphate—Pruritus—Doxorubicin—urinary bladder cancer	0.0002	0.000416	CcSEcCtD
Histamine Phosphate—Vomiting—Epirubicin—urinary bladder cancer	0.000194	0.000404	CcSEcCtD
Histamine Phosphate—Nausea—Methotrexate—urinary bladder cancer	0.000194	0.000404	CcSEcCtD
Histamine Phosphate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000193	0.000403	CcSEcCtD
Histamine Phosphate—Rash—Epirubicin—urinary bladder cancer	0.000193	0.000401	CcSEcCtD
Histamine Phosphate—Dermatitis—Epirubicin—urinary bladder cancer	0.000192	0.000401	CcSEcCtD
Histamine Phosphate—Headache—Epirubicin—urinary bladder cancer	0.000191	0.000398	CcSEcCtD
Histamine Phosphate—Dizziness—Doxorubicin—urinary bladder cancer	0.000187	0.000389	CcSEcCtD
Histamine Phosphate—Nausea—Epirubicin—urinary bladder cancer	0.000181	0.000378	CcSEcCtD
Histamine Phosphate—Vomiting—Doxorubicin—urinary bladder cancer	0.00018	0.000374	CcSEcCtD
Histamine Phosphate—Rash—Doxorubicin—urinary bladder cancer	0.000178	0.000371	CcSEcCtD
Histamine Phosphate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000178	0.000371	CcSEcCtD
Histamine Phosphate—Headache—Doxorubicin—urinary bladder cancer	0.000177	0.000369	CcSEcCtD
Histamine Phosphate—Nausea—Doxorubicin—urinary bladder cancer	0.000168	0.000349	CcSEcCtD
Histamine Phosphate—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.78e-05	0.000546	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—GSTP1—urinary bladder cancer	5.77e-05	0.000545	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	5.73e-05	0.000542	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—ESR1—urinary bladder cancer	5.73e-05	0.000541	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—RHOA—urinary bladder cancer	5.71e-05	0.00054	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	5.7e-05	0.000539	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—CREBBP—urinary bladder cancer	5.66e-05	0.000535	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	5.63e-05	0.000532	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—IL2—urinary bladder cancer	5.61e-05	0.00053	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TERT—urinary bladder cancer	5.59e-05	0.000528	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.53e-05	0.000522	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—S100B—urinary bladder cancer	5.47e-05	0.000517	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—RRM2—urinary bladder cancer	5.41e-05	0.000511	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—GLI1—urinary bladder cancer	5.39e-05	0.000509	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—ENO2—urinary bladder cancer	5.38e-05	0.000508	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	5.38e-05	0.000508	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—TYMS—urinary bladder cancer	5.36e-05	0.000506	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	5.32e-05	0.000502	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—NCOR1—urinary bladder cancer	5.3e-05	0.000501	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—GSTM1—urinary bladder cancer	5.3e-05	0.000501	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	5.22e-05	0.000493	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.21e-05	0.000492	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—RHOA—urinary bladder cancer	5.19e-05	0.00049	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.16e-05	0.000488	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.15e-05	0.000487	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—FGFR3—urinary bladder cancer	5.13e-05	0.000485	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—GPX1—urinary bladder cancer	5.07e-05	0.000479	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CREBBP—urinary bladder cancer	5.02e-05	0.000474	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.01e-05	0.000474	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	5.01e-05	0.000474	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—ENO2—urinary bladder cancer	5.01e-05	0.000474	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—ESR1—urinary bladder cancer	4.98e-05	0.000471	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—ERCC2—urinary bladder cancer	4.98e-05	0.000471	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—IGF1—urinary bladder cancer	4.96e-05	0.000468	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—EGFR—urinary bladder cancer	4.93e-05	0.000466	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—NCOR1—urinary bladder cancer	4.92e-05	0.000465	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.92e-05	0.000464	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.89e-05	0.000461	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	4.87e-05	0.00046	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	4.86e-05	0.000459	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—IL2—urinary bladder cancer	4.79e-05	0.000453	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.79e-05	0.000453	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	4.75e-05	0.000449	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—MTHFR—urinary bladder cancer	4.68e-05	0.000442	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—KRAS—urinary bladder cancer	4.66e-05	0.00044	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—PTGS2—urinary bladder cancer	4.64e-05	0.000438	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CXCL8—urinary bladder cancer	4.55e-05	0.00043	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.55e-05	0.00043	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—RHOA—urinary bladder cancer	4.54e-05	0.000429	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	4.52e-05	0.000427	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CREBBP—urinary bladder cancer	4.37e-05	0.000413	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.36e-05	0.000412	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—IL2—urinary bladder cancer	4.35e-05	0.000411	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CXCL8—urinary bladder cancer	4.34e-05	0.00041	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TERT—urinary bladder cancer	4.34e-05	0.00041	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—NQO1—urinary bladder cancer	4.34e-05	0.00041	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—IGF1—urinary bladder cancer	4.31e-05	0.000408	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—EGFR—urinary bladder cancer	4.29e-05	0.000406	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	4.24e-05	0.0004	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—ERBB2—urinary bladder cancer	4.2e-05	0.000397	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.13e-05	0.00039	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.13e-05	0.00039	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—KRAS—urinary bladder cancer	4.06e-05	0.000383	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—PTEN—urinary bladder cancer	4.04e-05	0.000382	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—NQO1—urinary bladder cancer	4.04e-05	0.000382	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CXCL8—urinary bladder cancer	3.99e-05	0.000377	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—FGFR3—urinary bladder cancer	3.98e-05	0.000376	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—HRAS—urinary bladder cancer	3.96e-05	0.000374	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—RHOA—urinary bladder cancer	3.95e-05	0.000373	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	3.95e-05	0.000373	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—ESR1—urinary bladder cancer	3.87e-05	0.000365	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—EP300—urinary bladder cancer	3.86e-05	0.000364	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.83e-05	0.000362	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—IL2—urinary bladder cancer	3.81e-05	0.00036	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.81e-05	0.00036	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PPARG—urinary bladder cancer	3.8e-05	0.000359	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.8e-05	0.000359	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.78e-05	0.000357	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCND1—urinary bladder cancer	3.71e-05	0.000351	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—RBX1—urinary bladder cancer	3.7e-05	0.000349	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—ERBB2—urinary bladder cancer	3.66e-05	0.000346	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—CREBBP—urinary bladder cancer	3.65e-05	0.000345	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.65e-05	0.000345	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	3.62e-05	0.000342	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—MMP9—urinary bladder cancer	3.6e-05	0.000341	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CDKN1A—urinary bladder cancer	3.59e-05	0.000339	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—PTEN—urinary bladder cancer	3.58e-05	0.000339	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TSC1—urinary bladder cancer	3.47e-05	0.000328	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CXCL8—urinary bladder cancer	3.47e-05	0.000328	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.46e-05	0.000327	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—HRAS—urinary bladder cancer	3.45e-05	0.000326	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.43e-05	0.000324	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—EP300—urinary bladder cancer	3.42e-05	0.000323	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.4e-05	0.000322	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CREBBP—urinary bladder cancer	3.39e-05	0.00032	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	3.37e-05	0.000318	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—TYMS—urinary bladder cancer	3.36e-05	0.000318	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—IGF1—urinary bladder cancer	3.35e-05	0.000316	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—EGFR—urinary bladder cancer	3.33e-05	0.000314	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—SRC—urinary bladder cancer	3.32e-05	0.000314	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	3.32e-05	0.000314	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	3.32e-05	0.000314	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—IL2—urinary bladder cancer	3.32e-05	0.000313	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—JAG1—urinary bladder cancer	3.31e-05	0.000312	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCND1—urinary bladder cancer	3.23e-05	0.000305	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.21e-05	0.000304	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—GPX1—urinary bladder cancer	3.18e-05	0.000301	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—KRAS—urinary bladder cancer	3.14e-05	0.000297	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—MMP9—urinary bladder cancer	3.14e-05	0.000296	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—TYMS—urinary bladder cancer	3.13e-05	0.000296	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.13e-05	0.000296	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CDKN1A—urinary bladder cancer	3.13e-05	0.000295	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	3.12e-05	0.000295	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—PTEN—urinary bladder cancer	3.12e-05	0.000295	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	3.1e-05	0.000293	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	3.1e-05	0.000293	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—RHOA—urinary bladder cancer	3.06e-05	0.000289	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.99e-05	0.000282	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PTGS2—urinary bladder cancer	2.99e-05	0.000282	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—MYC—urinary bladder cancer	2.98e-05	0.000281	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—EP300—urinary bladder cancer	2.98e-05	0.000281	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—GPX1—urinary bladder cancer	2.97e-05	0.00028	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.96e-05	0.00028	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	2.94e-05	0.000277	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—EGFR—urinary bladder cancer	2.91e-05	0.000275	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	2.91e-05	0.000275	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—SRC—urinary bladder cancer	2.89e-05	0.000273	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—ERBB2—urinary bladder cancer	2.84e-05	0.000268	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.8e-05	0.000264	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.77e-05	0.000262	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.77e-05	0.000262	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—KRAS—urinary bladder cancer	2.75e-05	0.00026	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.75e-05	0.000259	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.75e-05	0.000259	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	2.74e-05	0.000259	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.73e-05	0.000258	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CXCL8—urinary bladder cancer	2.69e-05	0.000254	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.69e-05	0.000254	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—S100B—urinary bladder cancer	2.68e-05	0.000253	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—HRAS—urinary bladder cancer	2.67e-05	0.000252	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.66e-05	0.000252	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.62e-05	0.000248	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PTEN—urinary bladder cancer	2.61e-05	0.000246	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—MYC—urinary bladder cancer	2.59e-05	0.000245	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—IL2—urinary bladder cancer	2.57e-05	0.000243	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	2.54e-05	0.00024	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—EGFR—urinary bladder cancer	2.54e-05	0.00024	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCND1—urinary bladder cancer	2.51e-05	0.000237	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.5e-05	0.000237	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—EP300—urinary bladder cancer	2.48e-05	0.000235	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.45e-05	0.000232	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—TP53—urinary bladder cancer	2.45e-05	0.000231	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MMP9—urinary bladder cancer	2.43e-05	0.00023	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.42e-05	0.000229	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—PTEN—urinary bladder cancer	2.42e-05	0.000229	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	2.41e-05	0.000227	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—KRAS—urinary bladder cancer	2.4e-05	0.000226	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PPARG—urinary bladder cancer	2.38e-05	0.000225	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	2.35e-05	0.000222	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—HRAS—urinary bladder cancer	2.34e-05	0.000221	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—EP300—urinary bladder cancer	2.31e-05	0.000218	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	2.29e-05	0.000216	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.26e-05	0.000214	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—SRC—urinary bladder cancer	2.24e-05	0.000212	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.23e-05	0.000211	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.23e-05	0.000211	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PPARG—urinary bladder cancer	2.22e-05	0.00021	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.21e-05	0.000209	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.15e-05	0.000203	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	2.13e-05	0.000201	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	2.13e-05	0.000201	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TP53—urinary bladder cancer	2.13e-05	0.000201	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TERT—urinary bladder cancer	2.12e-05	0.0002	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—HRAS—urinary bladder cancer	2.04e-05	0.000192	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MYC—urinary bladder cancer	2.01e-05	0.00019	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—EGFR—urinary bladder cancer	1.97e-05	0.000186	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.96e-05	0.000185	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	1.95e-05	0.000184	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	1.89e-05	0.000179	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	1.87e-05	0.000177	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.87e-05	0.000177	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.86e-05	0.000176	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—KRAS—urinary bladder cancer	1.86e-05	0.000175	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.85e-05	0.000174	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.81e-05	0.000171	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.81e-05	0.000171	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.79e-05	0.000169	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.76e-05	0.000166	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	1.75e-05	0.000165	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.73e-05	0.000164	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.72e-05	0.000162	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.71e-05	0.000162	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.71e-05	0.000162	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.7e-05	0.00016	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.7e-05	0.00016	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	1.66e-05	0.000157	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TP53—urinary bladder cancer	1.65e-05	0.000156	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.64e-05	0.000155	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	1.64e-05	0.000155	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PTEN—urinary bladder cancer	1.63e-05	0.000154	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	1.63e-05	0.000154	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.62e-05	0.000153	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.61e-05	0.000152	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.59e-05	0.000151	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—HRAS—urinary bladder cancer	1.58e-05	0.000149	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—EP300—urinary bladder cancer	1.56e-05	0.000147	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	1.54e-05	0.000145	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PTEN—urinary bladder cancer	1.52e-05	0.000144	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.51e-05	0.000143	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	1.5e-05	0.000142	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.5e-05	0.000142	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.46e-05	0.000138	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—EP300—urinary bladder cancer	1.45e-05	0.000137	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	1.39e-05	0.000131	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	1.32e-05	0.000124	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	1.31e-05	0.000124	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IL2—urinary bladder cancer	1.26e-05	0.000119	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	1.23e-05	0.000116	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.23e-05	0.000116	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.22e-05	0.000115	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.22e-05	0.000115	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	1.19e-05	0.000112	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.19e-05	0.000112	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	1.18e-05	0.000112	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.18e-05	0.000111	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.17e-05	0.00011	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.13e-05	0.000107	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—EP300—urinary bladder cancer	1.13e-05	0.000107	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.12e-05	0.000106	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.12e-05	0.000106	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—SRC—urinary bladder cancer	1.1e-05	0.000104	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.07e-05	0.000101	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.05e-05	9.94e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.89e-06	9.34e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MYC—urinary bladder cancer	9.84e-06	9.29e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	9.65e-06	9.11e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	9.62e-06	9.09e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	9.56e-06	9.03e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	9.09e-06	8.59e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PTEN—urinary bladder cancer	8.41e-06	7.95e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.34e-06	7.88e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TP53—urinary bladder cancer	8.08e-06	7.63e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—EP300—urinary bladder cancer	8.02e-06	7.58e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.02e-06	7.57e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—EP300—urinary bladder cancer	7.95e-06	7.51e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	7.73e-06	7.3e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.7e-06	7.28e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.31e-06	5.96e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.5e-06	5.2e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.25e-06	4.95e-05	CbGpPWpGaD
